← Leaderboards
Jonathan K. Alder
University Of Pittsburgh At Pittsburgh
$6,019,102
Attributed
$7,624,801
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,624,801 · 6
By mechanism
R01$6,185,166 · 3
R00$743,266 · 1
R21$423,179 · 1
K99$273,190 · 1
Top collaborators
- John F Mcdyer3 shared
- Aditi U Gurkar1 shared
- Michael J. Jurczak1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Elise Fouquerel$2,907,004
- Hong Wang$6,444,901
- John F McDyer$10,518,722
- Daniel Sullivan$151,639
- Angela Marie Hinchie$115,434
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseMediatingLungCell AgingIn VitroFunctional DisorderTelomereSenescenceMutationPhenotypeLung DiseasesGeneticCellsDna DamagePathogenesisBiologyProteinsMolecularPreventIdiopathic Pulmonary FibrosisElderlyChromosomesEpithelial CellsCell Type
Grant awards (18)
Mechanisms of Telomere-Mediated Lung Disease$747,166
R01 · FY2025 · HL · contact PI
The Role of Telomeres in Lung Transplant Recipient Immunity and Outcomes$707,484
R01 · FY2025 · HL
Novel aspects of Gdf15 biology and function$659,199
R01 · FY2025 · DK
SASP-ER platform to identify spatiotemporal senescence-associated secretome$423,179
R21 · FY2025 · AG · contact PI
Mechanisms of Telomere-Mediated Lung Disease$735,366
R01 · FY2024 · HL · contact PI
The Role of Telomeres in Lung Transplant Recipient Immunity and Outcomes$697,995
R01 · FY2024 · HL
The Role of Telomeres in Lung Transplant Recipient Immunity and Outcomes$723,541
R01 · FY2023 · HL
Mechanisms of Telomere-Mediated Lung Disease$384,352
R01 · FY2022 · HL · contact PI
Mechanisms of Telomere-Mediated Lung Disease$384,352
R01 · FY2021 · HL · contact PI
Mechanisms of Telomere-Mediated Lung Disease$384,352
R01 · FY2020 · HL · contact PI
Mechanisms of Telomere-Mediated Lung Disease$388,069
R01 · FY2019 · HL · contact PI
Mechanisms of Telomere-Mediated Lung Disease$373,290
R01 · FY2018 · HL · contact PI
Mechanisms of Teleomere-Mediated Emphysema$126,190
R00 · FY2016 · HL · contact PI
Mechanisms of Teleomere-Mediated Emphysema$122,810
R00 · FY2016 · HL · contact PI
Mechanisms of Teleomere-Mediated Emphysema$245,266
R00 · FY2015 · HL · contact PI
Mechanisms of Teleomere-Mediated Emphysema$249,000
R00 · FY2014 · HL · contact PI
Mechanisms of Teleomere-Mediated Emphysema$136,755
K99 · FY2013 · HL · contact PI
Mechanisms of Teleomere-Mediated Emphysema$136,435
K99 · FY2012 · HL · contact PI